Schistosomiasis in the first 1000 days
- PMID: 29170089
- DOI: 10.1016/S1473-3099(17)30490-5
Schistosomiasis in the first 1000 days
Erratum in
-
Corrections.Lancet Infect Dis. 2018 Mar;18(3):244. doi: 10.1016/S1473-3099(18)30050-1. Epub 2018 Feb 2. Lancet Infect Dis. 2018. PMID: 29398392 No abstract available.
Abstract
Infections during the first 1000 days-the period from conception to a child's second birthday-can have lifelong effects on health, because this is a crucial phase of growth and development. There is increasing recognition of the burden and potential effects of schistosomiasis in women of reproductive age and young children. Exposure to schistosomes during pregnancy can modulate infant immune development and schistosomiasis can occur from early infancy, such that the high disease burden found in adolescents is often due to accumulation of infections with long-lived schistosomes from early life. Women of reproductive age and young children are largely neglected in mass drug administration programmes, but early treatment could avert subsequent disease. We evaluate the evidence that early schistosomiasis has adverse effects on birth, growth, and development. We also discuss the case for expanding public health interventions for schistosomiasis in women of reproductive age and preschool-age children, and the need for further research to evaluate the potential of treating women pre-conception to maximise health across the life course.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
